Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study
Related Posts
Yoshihara E. Insulin-producing cells derived from expandable stem cell-derived endoderm are effective for the treatment of type 2 diabetes. Ann Transl Med. 2024 Dec 24;12(6):121.[...]
Ebrahimi N, Glassock RJ, Ghozloujeh ZG, Hassanein M, Narayan M, Abdipour A, Norouzi S. Artificial Intelligence in Clinical Trials: A Comparative Study With Nephrologists in[...]
Jakubek YA, Ma X, Stilp AM, Yu F, Bacon J, Wong JW, Aguet F, Ardlie K, Arnett DK, Barnes K, Bis JC, Blackwell T, Becker[...]